When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GSK - ViiV's two-drug HIV pill on par with three-drug regimen in late-stage study
GlaxoSmithKline PLC
ViiV Healthcare announces positive results from a Phase 3 clinical trial, TANGO, evaluating its two-drug HIV regimen of dolutegravir + lamivudine in virally suppressed patients switching from a TAF-containing three-drug regimen.
More news on: GlaxoSmithKline plc, Pfizer Inc., Shionogi & Co., Ltd., Healthcare stocks news,